Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,300 warrant series at 1,050 companies. 780 in the money, 59 expiring in the next 30 days, 37 waiting on a stockholder vote or other stated condition, 3 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Unit Warrants ($0.50) - Q2 2026 Securities Purchase Agreements | $0.0609 | $112.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Unit Warrants ($0.50) - Q3 2026 Securities Purchase Agreements (aggregate) | $0.0609 | $112.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Gold Sino Warrant (June 7, 2024) | $2.46 | $111.6M | 4, Oct 9, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Private Placement Warrants (assumed from Poema Global) | $2.46 | $111.6M | 20-F, Mar 31, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Public Warrants (assumed from Poema Global, listed as GGROW) | $2.46 | $111.6M | 20-F, Mar 31, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Kreos Initial Warrant (BlackRock Credit Agreement) | $0.4020 | $111.6M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Kreos Tranche C Warrant (BlackRock Credit Agreement) | $0.4020 | $111.6M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Symbiotic Capital Warrants (Initial Loan) | $0.4020 | $111.6M | 8-K, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| 2025 Pre-Funded Warrants (August 2025 underwritten offering) | $0.6020 | $110.8M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Five-year Warrants to purchase Non-Voting Common Stock (September 23, 2026 registered direct offering) | $0.8798 | $109.7M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Three-year Warrants to purchase Non-Voting Common Stock (August 29, 2025 registered direct offering) | $0.8798 | $109.7M | 424B5, Sep 24, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Public Warrants (former TLGY Public Warrants, USDEW) | $4.54 | $109.7M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Tranche A Sponsor Warrants | $4.54 | $109.7M | S-1/A, Sep 9, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Tranche B Sponsor Warrants | $4.54 | $109.7M | S-1/A, Sep 9, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Legacy LENZ OpCo Series A Preferred Stock warrants (converted at the Merger into common stock warrants, $10.64) | $3.48 | $109.5M | 10-Q, Nov 3, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| 2023 Placement Agent Warrants – $3.00, 41,738 shares (May 2023 tranche) | $5.67 | $108.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2023 Placement Agent Warrants – $3.00, expiring December 22, 2027 | $5.67 | $108.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2023 Placement Agent Warrants – $3.00, expiring January 10, 2028 | $5.67 | $108.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2023 Placement Agent Warrants – $3.00, expiring March 31, 2028 | $5.67 | $108.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Tranche A Warrants (exercisable for Series A-3 Convertible Preferred Stock) | $3.71 | $108.5M | S-3, Jun 5, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Tranche B Warrants (exercisable for Series A-4 Convertible Preferred Stock) | $3.71 | $108.5M | S-3, Jun 5, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Tranche C Warrants (exercisable for Series A-5 Convertible Preferred Stock) | $3.71 | $108.5M | S-3, Jun 5, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Consultant warrants (investor relations / business development consultant), issued July and September 2025, US$4.00 per ordinary share | $1.46 | $107.4M | 6-K EX-99.2, Aug 12, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| January 2026 Pre-Funded Warrants ($0.0001) | $1.80 | $106.4M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| January 2026 Series 1 Warrants ($13.42, exp. 2027-06-30) | $1.80 | $106.4M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| January 2026 Series 2 Warrants ($20.13, exp. 2030-12-31) | $1.80 | $106.4M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| May 2024 Pre-Funded Warrants ($0.0001) | $1.80 | $106.4M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Warrants to purchase 18,445 shares at $16.26 (legacy lender warrant) | $1.80 | $106.4M | 424B5, Jan 12, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| February 23, 2026 placement agent warrants (CAD$11.9744) | $2.51 | $105.3M | 6-K EX-99.1, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| February 26, 2024 warrants (US$4.4025) | $2.51 | $105.3M | 6-K EX-99.1, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| July 21, 2025 warrants (July Warrants, CAD$7.3579) | $2.51 | $105.3M | 6-K EX-99.1, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| June 12, 2025 warrants (June Warrants, CAD$5.0768) | $2.51 | $105.3M | 6-K EX-99.1, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| May 5, 2025 warrants (May Warrants, CAD$3.9779) | $2.51 | $105.3M | 6-K EX-99.1, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| September 28, 2026 placement agent warrants (CAD$9.4595) | $2.51 | $105.3M | 6-K EX-99.1, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Pre-funded common stock warrants (June 2023 private placement) | $2.15 | $105.2M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Preferred Tranche A Warrants (October 2025 private placement) to purchase Series A Convertible Voting Preferred Stock | $2.15 | $105.2M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| APSC Holdco II, LP warrants ($15.00, expiring 12/8/2028) | $23.57 | $105.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Corre and affiliates warrants (Warrant Nos. 2, 3 and 4; $15.00, expiring 12/8/2028) | $23.57 | $105.1M | 10-K, Mar 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Stellex Holder Tranche A Warrants (Warrant No. 5) | $23.57 | $105.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Stellex Holder Tranche B Warrants (Warrant No. 6) | $23.57 | $105.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| 2022 Common Warrants ($69.04) | $1.39 | $105.0M | 424B3, May 22, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 Common Warrants (January 2025 registered direct, $2.50) | $1.39 | $105.0M | 424B3, May 22, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 Pre-Funded Warrants ($0.0001) | $1.39 | $105.0M | 424B3, May 22, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Amended 2024 Common Warrants ($2.50) | $1.39 | $105.0M | 424B3, May 22, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Original 2024 Common Warrants ($10.00, unamended) | $1.39 | $105.0M | 424B3, May 22, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Private Placement Warrants — BTIG, LLC | $10.07 | $104.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Private Placement Warrants — Sponsor (Next Lion Sponsor Holdings LLC) | $10.07 | $104.4M | 4, May 5, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Public Warrants (included in IPO Units) | $10.07 | $104.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| August 2025 Common Stock Warrants (August 2025 CSWs) | $3.21 | $104.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| May 2025 Common Stock Warrants (May 2025 CSWs) | $3.21 | $104.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 |
AMFNAmerican Fusion Inc.$0.0609Last price
Unit Warrants ($0.50) - Q2 2026 Securities Purchase Agreements
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$112.2M
AMFNAmerican Fusion Inc.$0.0609Last price
Unit Warrants ($0.50) - Q3 2026 Securities Purchase Agreements (aggregate)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$112.2M
GGRGogoro Inc. Ordinary Shares$2.46Last price
Gold Sino Warrant (June 7, 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$111.6M
GGRGogoro Inc. Ordinary Shares$2.46Last price
Private Placement Warrants (assumed from Poema Global)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$111.6M
GGRGogoro Inc. Ordinary Shares$2.46Last price
Public Warrants (assumed from Poema Global, listed as GGROW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$111.6M
AKBAAkebia Therapeutics, Inc.$0.4020Last price
Kreos Initial Warrant (BlackRock Credit Agreement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$111.6M
AKBAAkebia Therapeutics, Inc.$0.4020Last price
Kreos Tranche C Warrant (BlackRock Credit Agreement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$111.6M
AKBAAkebia Therapeutics, Inc.$0.4020Last price
Symbiotic Capital Warrants (Initial Loan)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$111.6M
CMPXCompass Therapeutics, Inc.$0.6020Last price
2025 Pre-Funded Warrants (August 2025 underwritten offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$110.8M
PNBKPatriot National Bancorp, Inc.$0.8798Last price
Five-year Warrants to purchase Non-Voting Common Stock (September 23, 2026 registered direct offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$109.7M
PNBKPatriot National Bancorp, Inc.$0.8798Last price
Three-year Warrants to purchase Non-Voting Common Stock (August 29, 2025 registered direct offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$109.7M
USDEStablecoinX Inc.$4.54Last price
Public Warrants (former TLGY Public Warrants, USDEW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$109.7M
USDEStablecoinX Inc.$4.54Last price
Tranche A Sponsor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$109.7M
USDEStablecoinX Inc.$4.54Last price
Tranche B Sponsor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$109.7M
LENZLENZ Therapeutics, Inc.$3.48Last price
Legacy LENZ OpCo Series A Preferred Stock warrants (converted at the Merger into common stock warrants, $10.64)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$109.5M
ALMUAeluma, Inc.$5.67Last price
2023 Placement Agent Warrants – $3.00, 41,738 shares (May 2023 tranche)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$108.9M
ALMUAeluma, Inc.$5.67Last price
2023 Placement Agent Warrants – $3.00, expiring December 22, 2027
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$108.9M
ALMUAeluma, Inc.$5.67Last price
2023 Placement Agent Warrants – $3.00, expiring January 10, 2028
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$108.9M
ALMUAeluma, Inc.$5.67Last price
2023 Placement Agent Warrants – $3.00, expiring March 31, 2028
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$108.9M
UNCYUnicycive Therapeutics, Inc.$3.71Last price
Tranche A Warrants (exercisable for Series A-3 Convertible Preferred Stock)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$108.5M
UNCYUnicycive Therapeutics, Inc.$3.71Last price
Tranche B Warrants (exercisable for Series A-4 Convertible Preferred Stock)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$108.5M
UNCYUnicycive Therapeutics, Inc.$3.71Last price
Tranche C Warrants (exercisable for Series A-5 Convertible Preferred Stock)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$108.5M
ADAGAdagene Inc. American Depositary Shares$1.46Last price
Consultant warrants (investor relations / business development consultant), issued July and September 2025, US$4.00 per ordinary share
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$107.4M
FHTXFoghorn Therapeutics Inc.$1.80Last price
January 2026 Pre-Funded Warrants ($0.0001)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$106.4M
FHTXFoghorn Therapeutics Inc.$1.80Last price
January 2026 Series 1 Warrants ($13.42, exp. 2027-06-30)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$106.4M
FHTXFoghorn Therapeutics Inc.$1.80Last price
January 2026 Series 2 Warrants ($20.13, exp. 2030-12-31)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$106.4M
FHTXFoghorn Therapeutics Inc.$1.80Last price
May 2024 Pre-Funded Warrants ($0.0001)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$106.4M
FHTXFoghorn Therapeutics Inc.$1.80Last price
Warrants to purchase 18,445 shares at $16.26 (legacy lender warrant)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$106.4M
DPRODraganfly Inc.$2.51Last price
February 23, 2026 placement agent warrants (CAD$11.9744)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.3M
DPRODraganfly Inc.$2.51Last price
February 26, 2024 warrants (US$4.4025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.3M
DPRODraganfly Inc.$2.51Last price
July 21, 2025 warrants (July Warrants, CAD$7.3579)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.3M
DPRODraganfly Inc.$2.51Last price
June 12, 2025 warrants (June Warrants, CAD$5.0768)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.3M
DPRODraganfly Inc.$2.51Last price
May 5, 2025 warrants (May Warrants, CAD$3.9779)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.3M
DPRODraganfly Inc.$2.51Last price
September 28, 2026 placement agent warrants (CAD$9.4595)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.3M
NERVMinerva Neurosciences, Inc.$2.15Last price
Pre-funded common stock warrants (June 2023 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.2M
NERVMinerva Neurosciences, Inc.$2.15Last price
Preferred Tranche A Warrants (October 2025 private placement) to purchase Series A Convertible Voting Preferred Stock
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.2M
TISITeam, Inc.$23.57Last price
APSC Holdco II, LP warrants ($15.00, expiring 12/8/2028)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.1M
TISITeam, Inc.$23.57Last price
Corre and affiliates warrants (Warrant Nos. 2, 3 and 4; $15.00, expiring 12/8/2028)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.1M
TISITeam, Inc.$23.57Last price
Stellex Holder Tranche A Warrants (Warrant No. 5)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.1M
TISITeam, Inc.$23.57Last price
Stellex Holder Tranche B Warrants (Warrant No. 6)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.1M
CBUSCibus, Inc.$1.39Last price
2022 Common Warrants ($69.04)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.0M
CBUSCibus, Inc.$1.39Last price
2025 Common Warrants (January 2025 registered direct, $2.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.0M
CBUSCibus, Inc.$1.39Last price
2025 Pre-Funded Warrants ($0.0001)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.0M
CBUSCibus, Inc.$1.39Last price
Amended 2024 Common Warrants ($2.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.0M
CBUSCibus, Inc.$1.39Last price
Original 2024 Common Warrants ($10.00, unamended)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$105.0M
Private Placement Warrants — BTIG, LLC
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$104.4M
Private Placement Warrants — Sponsor (Next Lion Sponsor Holdings LLC)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$104.4M
Public Warrants (included in IPO Units)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$104.4M
FLNTFluent, Inc.$3.21Last price
August 2025 Common Stock Warrants (August 2025 CSWs)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$104.2M
FLNTFluent, Inc.$3.21Last price
May 2025 Common Stock Warrants (May 2025 CSWs)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$104.2M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,061 dilution snapshots. 4,846 of 5,300 series state an exercise price and 3,366 an expiry date. 98 record when exercise begins; that count grows as companies are re-extracted. 633 series are left off because their figures could not be restated for a stock split. 20 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.